Our state-of-the art amenities facilitate our world-class research

Our cutting-edge drug and vaccine discovery and development resources are also available to external research groups and industry.

Explore our facilities and resources below, and if you’d like more information on any of our services, please get in touch.

Wide-ranging resources

Our range of facilities covers the entire spectrum of drug discovery and development, including:

Glycobioanalytical Facility

Our Glycobioanalytical Facility includes the Glycomics Array Facility and a bioanalytical suite.

Flow Cytometry Facility

Our Flow Cytometry Facility offers equipment and expertise for cell and particle analysis and sorting.

Joint Laboratory for Quantum Molecular Biophysics

The physics of biological molecules govern the chemistry of life. For example, the way DNA folds influences how genes are regulated and incorrectly folded proteins are the underlying mechanism of degenerative diseases including Alzheimer’s, Huntington’s and Parkinson’s. Three-dimensional structures on the surface of an infectious agent also determine its ability to infect a host cell. Hence, a deeper understanding of the three-dimensional structure of folded biomolecules greatly informs our ability to rationally design drugs with greater specificity and efficacy.

The Joint Laboratory for Quantum Molecular Biophysics is a collaboration between the Institute for Glycomics and the Centre for Quantum Dynamics, Griffith University.

The Joint Laboratory fosters investigations at the junction between physics and biology to develop technologies that enable us to observe and control the folding of biomolecules with quantum precision. Biologic Drug Optimisation and de novo Design Biologics are medicinal products obtained from living biological systems that include proteins, antibodies, vaccines, hormones and gene therapy. Biologics are becoming increasingly attractive in drug development because of their high specificity. However, biologic drugs are generally more costly to manufacture and less stable than small molecule drugs.

We are developing computational and experimental Codon Optimisation techniques to reduce the cost of the production and increase drug shelf-life and stability.

Metalloglycomics-gold-and platinum-based therapeutic agents

Gold, platinum and other metals have been used in medicine for millennia. More recent metal-based drug development has renewed interest in their use to treat a range of human diseases including cancer, rheumatoid arthritis, and viral and parasitic diseases. Metalloglycomics is a specialised discipline at the intersection of metal- and carbohydrate-chemistry that has the potential to transform the way we treat cancer, autoimmune disease and infectious diseases.

In vivo models

We have in-house access to a range of in vivo models and a substantial, fully staffed facility, including PC2 and PC3 suites. We also have animal models for autoimmune inflammatory diseases.

Clinical samples and cell lines

We have a growing number of clinical samples and novel cell-lines relevant to infectious diseases and cancer research.

Want to know more?

Get in touch with the Institute for Glycomics